Table Of Content

10/01/2019 LD-2 Disclosure Form Clerk of the House of Representatives Secretary of the Senate Legislative Resource Center Office of Public Records B-106 Cannon Building 232 Hart Building Washington, DC 20515 Washington, DC 20510 LOBBYING REPORT http://lobbyingdisclosure.house.gov http://www.senate.gov/lobby Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page 1. Registrant Name Organization/Lobbying Firm Self Employed Individual Bayer Corporation (consolidated report) 2. Address Address1 801 Pennsylvania Ave., NW Suite 745 Address2 City WASHINGTON State DC Zip Code 20004 Country USA 3. Principal place of business (if different than line 2) City State Zip Code Country 4a. Contact Name b. Telephone Number c. E-mail 5. Senate ID# Mr. Brian McCullough 2027378900 [email protected] 5632-12 7. Client Name Self Check if client is a state or local government or instrumentality 6. House ID# Bayer Corporation (consolidated report) 312570000 TYPE OF REPORT 8. Year 2015 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31) 9. Check if this filing amends a previously filed version of this report 10. Check if this is a Termination Report Termination Date 11. No Lobbying Issue Activity INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 12. Lobbying 13. Organizations INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were: Less than $5,000 Less than $5,000 $5,000 or more $ $5,000 or more $ 1,750,000.00 Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the 14. REPORTING Check box to indicate expense accounting method. registrant by any other entity for lobbying activities on behalf of the See instructions for description of options. client). Method A. Reporting amounts using LDA definitions only Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code 4/20/2015 Signature Digitally Signed By: Brian McCullough Date 6:58:36 PM https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 1/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code AGR 16. Specific lobbying issues Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA) 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Matthew Perin Donna Stephens James McVaney Staff Member, House Oversight Feder. Subcommittee '05- '06; Staff Member, House Oversight Tech. Subcommittee Ursula Wojciechowski '04; Clerk, House Oversight Tech. Subcommittee '03; Staff Assistant, House Oversight Govt. Efficiency Subcommittee '02 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 2/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code BUD 16. Specific lobbying issues Monitor legislative and administrative action on appropriations and budget. S.Con.Res. 11, Budget Resolution. Provisions relating to Medicare policy. H.Con.Res. 27, Budget Resolution. Provisions relating to Medicare policy. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Legislative Director, Sen. Kay Hagan '12-'14; Legislative Director, Sen. Ernest Hollings '04-05; Legislative Assistant, Brian Nagle Sen. Ernest Hollings '00-'04; Legislative Correspondent, Sen. Ernest Hollings '99-'00. Matthew Perin 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 3/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code CHM 16. Specific lobbying issues Monitor legislative and administrative action related to the Toxic Substances Control Act. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian McCullough 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 4/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code CPT 16. Specific lobbying issues Monitor legislative and administrative action related to intellectual property protection. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Legislative Director, Sen. Kay Hagan '12-'14; Legislative Director, Sen. Ernest Hollings '04-05; Legislative Assistant, Brian Nagle Sen. Ernest Hollings '00-'04; Legislative Correspondent, Sen. Ernest Hollings '99-'00. 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 5/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code ENV 16. Specific lobbying issues S.535, Energy Efficiency Improvement Act of 2015. H.R. 896, Regulatory Certainty Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Matthew Perin Staff Member, House Oversight Feder. Subcommittee '05- '06; Staff Member, House Oversight Tech. Subcommittee Ursula Wojciechowski '04; Clerk, House Oversight Tech. Subcommittee '03; Staff Assistant, House Oversight Govt. Efficiency Subcommittee '02 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 6/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code HCR 16. Specific lobbying issues Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA) 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Donna Stephens Julie Corcoran Brian McCullough Legislative Director, Sen. Kay Hagan '12-'14; Legislative Director, Sen. Ernest Hollings '04-05; Legislative Assistant, Brian Nagle Sen. Ernest Hollings '00-'04; Legislative Correspondent, Sen. Ernest Hollings '99-'00. 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 7/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code MMM 16. Specific lobbying issues Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Donna Stephens Julie Corcoran Legislative Director, Sen. Kay Hagan '12-'14; Legislative Director, Sen. Ernest Hollings '04-05; Legislative Assistant, Brian Nagle Sen. Ernest Hollings '00-'04; Legislative Correspondent, Sen. Ernest Hollings '99-'00. 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 8/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAR 16. Specific lobbying issues Monitor legislative and administrative action related to miscellaneous tariff legislation. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian McCullough Matthew Perin 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 9/12 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAX 16. Specific lobbying issues Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Donna Stephens Brian McCullough Staff Member, House Oversight Feder. Subcommittee '05- '06; Staff Member, House Oversight Tech. Subcommittee Ursula Wojciechowski '04; Clerk, House Oversight Tech. Subcommittee '03; Staff Assistant, House Oversight Govt. Efficiency Subcommittee '02 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=DFEB17AE-D830-4CBD-87AA-CC4F13D4A161&filingTypeID=51 10/12